STEPHANIE RODRIGUEZ: Open Payments
NPI 1801561378 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,726 in 174 payments from 17 companies in 2025. Trend: 2023 $950 · 2024 $1,610 · 2025 $2,726
Food & beverage: $2,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $614 |
| Madrigal Pharmaceuticals | 19 | $315 |
| Janssen Biotech, Inc. | 21 | $283 |
| GENZYME CORPORATION | 11 | $259 |
| Ardelyx, Inc. | 12 | $254 |
| Aimmune Therapeutics, Inc. | 25 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Regeneron Healthcare Solutions, Inc. | 5 | $146 |
| Gilead Sciences, Inc. | 6 | $108 |
| Intercept Pharmaceuticals, Inc. | 5 | $96 |
Products named: DUPIXENT, REZDIFFRA, TREMFYA, IBSRELA, RINVOQ, CREON, ZENPEP, OCALIVA.
Industry payments across SC — which companies pay providers there.
